The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer
20 minutes
Posted Sep 13, 2022 at 9:42 am.
0:00
20:25
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Peter O'Donnell describes the study.
Previous
Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer
Next
Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer
← See all 493 episodes of The Uromigos
